Longeveron (LGVN) CMO Nataliya Agafonova Receives RSU Award

What Happened
Nataliya Agafonova, Chief Medical Officer of Longeveron Inc. (LGVN), was granted 286,000 restricted stock units (RSUs) on August 19, 2026. The award was reported on a Form 4 filed August 21, 2026, and is listed at $0.00 per share (no cash was paid at grant). The transaction is coded as an award/grant (A) rather than a purchase or sale.

Key Details

• Transaction date: 2026-08-19; Form 4 filed: 2026-08-21 (appears timely under the two-business-day rule).
• Grant: 286,000 RSUs @ $0.00; total cash paid at grant = $0.
• Footnotes: F1 indicates these are time‑based vesting RSUs; F2 notes the RSUs are subject to future vesting.
• Shares owned after the transaction: not disclosed in the supplied transaction summary.
• Transaction type: Award/Grant (A) — not an open‑market buy or sale.

Context
RSU grants are a form of compensation and typically vest over time; they do not represent immediate cash outlay or an expressed buy/sell market view. For investors, grants are common for executives and mainly reflect compensation structure rather than direct insider confidence; future vesting and any subsequent sales would provide clearer signals.